Search

This analysis reviews the development of Jungian typology and the Myers Briggs Type Indicator (MBTI). It provides a survey of empirical studies of Jungian personality type and religious phenomena and issues that use the Myers Briggs Type Indicator. It documents a) how individuals relate to and experience religion, b) what they expect from religious participation, c) how likely they are to affiliate with religious groups, and d) suggests that the sensing/intuitive preference-set is the most salient to religion. Sensing preferences were associated with sharper religious boundaries and discomfort with religious doubt and change, judging preferences with attraction to the structure of religion, and perceiving with religious experience. Sensing, feeling, and judging preferences were more common among religious joiners. A history of the development of Jung's typology is provided. [ABSTRACT FROM AUTHOR]

Huntington's Disease-like 2 (HDL2) is a progressive, autosomal dominant, neurodegenerative disorder with marked clinical and pathological similarities to Huntington's disease (HD). The causal mutation is a CTG/CAG expansion mutation on chromosome 16q24.3, in a variably spliced exon of junctophilin-3. The frequency of HDL2 was determined in nine independent series of patients referred for HD testing or selected for the presence of an HD-like phenotype in North America or Japan. The repeat length, ancestry, and age of onset of all North American HDL2 cases were determined. The results show that HDL2 is very rare, with a frequency of 0 to 15% among patients in the nine case series with an HD-like presentation who do not have the HD mutation. HDL2 is predominantly, and perhaps exclusively, found in individuals of African ancestry. Repeat expansions ranged from 44 to 57 triplets, with length instability in maternal transmission detected in a repeat of r2=0.29, p=0.0098). The results further support the evidence that the repeat expansion at the chromosome 16q24.3 locus is the direct cause of HDL2 and provide preliminary guidelines for the genetic testing of patients with an HD-like phenotype.